TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK)

CUSIP: 874060205

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / SPONSORED ADS
Total 13F shares
2,487,812
Share change
+507,573
Total reported value
$52,101,000
Price per share
$20.90
Number of holders
14
Value change
+$10,712,473
Number of buys
7
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 874060205?
CUSIP 874060205 identifies TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
PARAMETRIC PORTFOLIO ASSOCIATES LLC
13F
Company
class O/S missing
1,791,765
$43,737,000 31 Mar 2018
13F
World Asset Management Inc
13F
Company
class O/S missing
62,891
$1,514,000 31 Mar 2018
13F
Pinnacle Wealth Planning Services, Inc.
13F
Company
class O/S missing
24,301
$593,000 31 Mar 2018
13F
QUADRANT CAPITAL GROUP LLC
13F
Company
class O/S missing
6,367
$149,000 31 Mar 2018
13F
GLENMEDE TRUST CO NA
13F
Company
class O/S missing
3,076
$86,000 31 Mar 2018
13F
Hexavest Inc.
13F
Company
class O/S missing
1,134
$28,000 31 Mar 2018
13F
Private Capital Group, LLC
13F
Company
class O/S missing
565
$14,000 31 Mar 2018
13F
Geneos Wealth Management Inc.
13F
Company
class O/S missing
364
$8,000 31 Mar 2018
13F
Gemmer Asset Management LLC
13F
Company
class O/S missing
111
$3,000 31 Mar 2018
13F
First Horizon Advisors, Inc.
13F
Company
class O/S missing
65
$1,000 31 Mar 2018
13F

Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q2 2018

As of 30 Jun 2018, TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) was held by 14 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,487,812 shares. The largest 10 holders included Parametric Portfolio Associates LLC, GLENMEDE TRUST CO NA, Pacer Advisors, Inc., NorthCoast Asset Management LLC, FNY Investment Advisers, LLC, World Asset Management Inc, Pinnacle Wealth Planning Services, Inc., Kepos Capital LP, QUADRANT CAPITAL GROUP LLC, and Hexavest Inc.. This page lists 14 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders
10
Q2 2018 holders
14
Holder diff
4
Investor Q1 2018 Shares Q2 2018 Shares Share Diff Share Chg % Q1 2018 Value $ Q2 2018 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.